VEGFA and neoplasm: In contrast to traditional AAT, normalizing tumor vasculature with low-dose VEGF blockade is an alternative promising approach that remodels a favorable tumor microenvironment for optimally combining other anticancer therapies to synergize effectiveness 7,52.